Analytica
Analytica Limited is a Brisbane-based medical device company that developed the PeriCoach e-health system for women's pelvic floor disorders and the AutoStart IV infusion burette, serving consumers via PeriCoach.com and hospitals via regional distributors.
- Company typePublic
- Founded1998
- HeadquartersBrisbane, Australia
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Analytica does
Analytica Limited (ASX: ALT, ABN 12 006 464 866) is a Brisbane-based medical device company that developed two complementary product lines: PeriCoach, an e-health system for the conservative treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse in women, and AutoStart, an IV infusion burette with automatic flow-restart functionality. The company's lead asset, PeriCoach, comprises a pelvic floor exercise device equipped with patented force-sensor and motion-sensing technology, paired with a smartphone application and the PeriCloud web portal that enables physicians to remotely monitor patient compliance and symptom progression. AutoStart is a specialised IV burette whose enhanced float mechanism restarts fluid flow after medicated bolus delivery, designed to reduce nurse intervention; it received USFDA 510(k) clearance in 2010 and is listed on the Australian Register of Therapeutic Goods.
The company operated two distinct go-to-market models. PeriCoach was sold direct-to-consumer globally through the owned PeriCoach.com storefront, leveraging regulatory clearances in Australia (TGA), Europe (CE mark), and the United States (FDA 510(k)) for Stress Urinary Incontinence, plus TGA clearance for Pelvic Organ Prolapse. AutoStart was distributed through regional partners across Australia/New Zealand, Taiwan/South-East Asia, and Brazil/South America, and was listed on the Queensland Health purchasing schedule. Distribution was supplemented in 2018 by a US contract manufacturer for PeriCoach, and in May 2022 the company received ISO 13485:2016 certification enabling global sales of in-house manufactured product.
From 2014 through 2021 Analytica funded operations primarily through a series of small rights issues, placements, and option exercises totalling roughly AUD 8.7M, supplemented by R&D tax incentives from the Australian Taxation Office (AUD 649K for FY2020 and AUD 269K for FY2021) and a $4.8M federal grant commitment announced in May 2022 for a manufacturing facility in Maryborough, Queensland. The company entered voluntary administration on 13 June 2023 following an ASX suspension and the May 2023 resignation of CEO Geoff Daly. On 25 July 2023 creditors approved a Deed of Company Arrangement proposed by Stratos MedTech Pty Ltd and Stratos MedTech Holdings Pty Ltd, and the company's assets were sold. The listed entity is now described on its own website as 'Subject to Deed of Company Arrangement,' and no revenue figures have been publicly disclosed.
Analytica firmographics
Firmographics- Name
- Analytica
- Legal name
- Analytica Limited
- Website
- https://analyticamedical.com
- Company type
- Public
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Analytica Limited is a Brisbane-based medical device company that developed the PeriCoach e-health system for women's pelvic floor disorders and the AutoStart IV infusion burette, serving consumers via PeriCoach.com and hospitals via regional distributors.
- Ownership category
- akta.pro rank
Where Analytica is headquartered
LocationHeadquarters
- HQ city
- Brisbane
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Analytica business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- PeriCoach Device and System Sales: Sale of PeriCoach device, web portal access, and smartphone app for treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse
- AutoStart Infusion System Sales: Sale of AutoStart burette devices with enhanced float system for IV fluid infusion
Go-to-market motion3 records
Distribution channels3 records
Marketing channels3 records
Analytica product offering
Product offeringCore offering
Analytica develops, manufactures, and commercialises Class I and Class IIa medical devices. Its lead product, the PeriCoach System, is an e-health platform combining a pelvic floor muscle-sensing device, a smartphone app, and a cloud-based physician portal (PeriCloud) for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Its secondary product, the AutoStart Infusion System, is an IV burette with automatic flow-restart and flushing capability for hospital infusion therapy.
Product overview
Analytica offers a portfolio of medical device products focused on two main areas: women's health and infusion systems. The PeriCoach System is an e-health platform combining a pelvic floor exercise device with a smartphone app and PeriCloud web portal for remote patient monitoring. The AutoStart Infusion System is a specialized IV burette that automatically restarts fluid flow after medication delivery. The company also received ISO 13485:2016 certification for design, development, production, sales and distribution of PeriCoach.
Differentiator
Problem solved
Functional benefit
Brands
- PeriCoach: An e-health treatment system for women who suffer Stress Urinary Incontinence. Comprises a device, web portal and smartphone app that evaluates pelvic floor muscle activity.
- AutoStart Infusion System
Products and services
- PeriCoach System An e-health treatment system for women suffering Stress Urinary Incontinence and Pelvic Organ Prolapse. It comprises a pelvic floor muscle-sensing device, a smartphone app, and the PeriCloud web portal that lets physicians remotely monitor whether a patient is performing pelvic floor exercises correctly and whether her condition is improving. The system holds TGA (Australia), CE mark (Europe), and FDA 510(k) (US) regulatory clearances and is sold direct-to-consumer via PeriCoach.com.
- AutoStart Infusion System An IV fluid infusion system (burette) with an enhanced float mechanism that automatically restarts IV fluid flow after delivery of a predetermined medication amount, plus an integrated flushing feature allowing the needle-less injection port and medication delivery syringe to be flushed with saline from the IV bag. Designed for hospital and clinical IV infusion therapy to reduce nurse intervention and alarm fatigue, with an estimated $2 cost saving per medication event. Distributed via regional partners across Australia/New Zealand, Taiwan/South-East Asia, and Brazil/South America and listed on the Queensland Health purchasing schedule.
Quantifiable outcome
- Randomised controlled clinical trial demonstrated PeriCoach non-inferiority to traditional supervised pelvic floor physical therapy for Stress Urinary Incontinence
- +2 more outcomes
Companies that use Analytica
Customer profileSegments3 records
Ideal customer profiles2 records
Analytica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Analytica partnerships and signals
Strategic signalScale indicators7 records
Recent moves8 records
Expansion highlights4 records
Analytica competitors and assessment
Company assessmentDirect peers
- Viveve Medical: Viveve develops energy-based women's health devices for vaginal laxity, stress urinary incontinence, and sexual function—targeting the same SUI patient cohort as PeriCoach through a device-based clinical positioning.
- Atlantic Therapeutics: Atlantic Therapeutics markets the INNOVO electrical muscle stimulation system for stress urinary incontinence, directly competing with PeriCoach in the conservative/e-health treatment of pelvic floor dysfunction.
- Caldera Medical: Caldera Medical develops surgical and conservative devices for female pelvic health including stress urinary incontinence, providing direct comparability to Analytica's PeriCoach in the women's pelvic floor market.
- Laborie Medical Technologies: Laborie is a urogynecology and pelvic health medical device company focused on diagnostics and therapeutics for incontinence and pelvic floor disorders—overlapping directly with PeriCoach's clinical use case.
- Renovia Inc. Renovia developed the Leva pelvic floor digital therapeutic for stress urinary incontinence—a direct e-health/biofeedback competitor to PeriCoach targeting the same patient population with a similar remote-monitoring clinical positioning.
Broad incumbents
- ICU Medical: ICU Medical produces IV infusion and oncology drug-delivery products and is a competitor for the infusion-pump accessories market that AutoStart's automatic flow-restart burette targets.
- Baxter International: Baxter is a major manufacturer of IV infusion pumps, sets, and disposables—operating as a broad incumbent competing for hospital IV contracts where AutoStart's clinical and cost-savings proposition would be evaluated.
- Axonics: Axonics offers sacral neuromodulation systems to treat bladder and bowel dysfunction including incontinence—a larger, broader incumbent in the SUI/overactive bladder treatment space that overlaps with PeriCoach's downstream surgical alternatives.
- B. Braun: B. Braun is a large medical device and IV therapy player with infusion and disposables portfolios that directly overlap with Analytica's AutoStart IV burette/infusion system.
- Becton, Dickinson and Company (BD): BD offers a broad portfolio of IV therapy, infusion sets, and medication-delivery products that compete for the same hospital purchasing decisions where AutoStart's value proposition is positioned.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Analytica social profiles
Digital presenceAnalytica compliance and trust
Trust signalCompliance3 records
Analytica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Analytica leadership team
Management profileNumber of profiles
Profiles3 records
Analytica funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Analytica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Analytica
What does Analytica do?
Analytica develops, manufactures, and commercialises Class I and Class IIa medical devices. Its lead product, the PeriCoach System, is an e-health platform combining a pelvic floor muscle-sensing device, a smartphone app, and a cloud-based physician portal (PeriCloud) for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse. Its secondary product, the AutoStart Infusion System, is an IV burette with automatic flow-restart and flushing capability for hospital infusion therapy.
Is Analytica a public or private company?
Analytica is a public company. It is classified as public and is currently operating.
When was Analytica founded?
Analytica was founded in 1998. It employs 1 to 10 people.
Where is Analytica based?
Analytica is headquartered in Brisbane, Australia, in the Oceania region.
How does Analytica make money?
Two revenue lines are on record. PeriCoach Device and System Sales are the primary driver. The others are autoStart Infusion System Sales.
Who are Analytica's main competitors?
Direct peers on record are Viveve Medical, Atlantic Therapeutics, Caldera Medical, Laborie Medical Technologies and Renovia Inc.. Broad incumbents are ICU Medical, Baxter International, Axonics, B. Braun and Becton, Dickinson and Company (BD).
Does Analytica have an API?
No public API is recorded for Analytica.